Activation of melatonin receptor 1 by CRISPR‐Cas9 activator ameliorates cognitive deficits in an Alzheimer's disease mouse model
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Pineal Research"
DOI: 10.1111/jpi.12787
Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the presence of neurotoxic beta‐amyloid (Aβ) in the brain. Melatonin receptors have been reported to associate with aging and AD, and their expression decreased with… read more here.
Keywords: cas9 activator; activation; melatonin; melatonin receptor ... See more keywords